| Authors: |
Huang FW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. levi_garraway@dfci.harvard.edu franklin_huang@dfci.harvard.edu ipowell@med.wayne.edu rubinma@med.cornell.edu.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Cancer Program, the Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Mosquera JM; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian, New York, New York.; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York., Garofalo A; Cancer Program, the Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Oh C; Cancer Program, the Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Baco M; Cancer Program, the Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Amin-Mansour A; Cancer Program, the Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Rabasha B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Cancer Program, the Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Bahl S; Cancer Program, the Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Mullane SA; Cancer Program, the Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Robinson BD; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian, New York, New York.; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York., Aldubayan S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Cancer Program, the Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Khani F; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York., Karir B; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian, New York, New York.; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York., Kim E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Cancer Program, the Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Chimene-Weiss J; Cancer Program, the Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Hofree M; Cancer Program, the Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Romanel A; Centre for Integrative Biology, University of Trento, Trento, Italy., Osborne JR; Centre for Integrative Biology, University of Trento, Trento, Italy.; Department of Radiology, Weill Cornell Medicine, New York, New York., Kim JW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Cancer Program, the Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Azabdaftari G; Department of Pathology, Roswell Park Cancer Institute, Roswell Park, New York., Woloszynska-Read A; Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Roswell Park, New York., Sfanos K; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland., De Marzo AM; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland., Demichelis F; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian, New York, New York.; Centre for Integrative Biology, University of Trento, Trento, Italy., Gabriel S; Cancer Program, the Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Cancer Program, the Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Mesirov J; Cancer Program, the Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Department of Medicine, University of California, San Diego, La Jolla, California.; Moores Cancer Center, University of California, San Diego, La Jolla, California., Tamayo P; Cancer Program, the Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Department of Medicine, University of California, San Diego, La Jolla, California.; Moores Cancer Center, University of California, San Diego, La Jolla, California., Rubin MA; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian, New York, New York. levi_garraway@dfci.harvard.edu franklin_huang@dfci.harvard.edu ipowell@med.wayne.edu rubinma@med.cornell.edu.; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York.; Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, New York, New York., Powell IJ; Barbara Ann Karmanos Cancer Institute, Detroit, Michigan. levi_garraway@dfci.harvard.edu franklin_huang@dfci.harvard.edu ipowell@med.wayne.edu rubinma@med.cornell.edu.; Department of Urology, Wayne State University School of Medicine, Detroit, Michigan., Garraway LA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. levi_garraway@dfci.harvard.edu franklin_huang@dfci.harvard.edu ipowell@med.wayne.edu rubinma@med.cornell.edu.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Cancer Program, the Broad Institute of Harvard and MIT, Cambridge, Massachusetts. |
